Prurigo Nodularis Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 17
SKU : PH2151
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
Who are the key players in Prurigo Nodularis Treatment Market ?
Global Prurigo Nodularis Treatment Market reached USD 964.3 million in 2022 and is projected to witness lucrative growth by reaching up to USD 1.1 billion by 2031.
Who are the Key Players of Prurigo Nodularis Treatment Market ?
The major global players include Menlo Therapeutics Inc., Pfizer Inc, Sanofi S.A., Kiniksa Pharmaceuticals Ltd., Astellas Pharma Inc, Eli Lilly and Company, GlaxoSmithKline, Galderma S.A., Trevi Therapeutics Inc, and Regeneron Pharmaceuticals Inc.
Related Reports
pharmaceuticalsPruritus Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 17
Starting from
$4350
pharmaceuticalsAtopic Dermatitis Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 19
Starting from
$4350
medical-devicesDermatoscope Devices Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Published: 2024 February 08
Starting from
$4350
pharmaceuticalsSkin Cancer Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 March 01
Starting from
$4350
pharmaceuticalsDermatitis Herpetiformis Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 01
Starting from
$4350
pharmaceuticalsAcne Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 15
Starting from
$4350